ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Propanc Biopharma, Inc.
0.1950
+0.0052
2.74%
盤前：
0.1951
0.0001
+0.05%
08:07 EST
成交量：
61.65萬
成交額：
11.48萬
市值：
294.28萬
市盈率：
-0.04
高：
0.1950
開：
0.1841
低：
0.1785
收：
0.1898
52周最高：
11.00
52周最低：
0.0002
股本：
1,509.11萬
流通股本：
673.39萬
量比：
0.07
換手率：
9.16%
股息：
- -
股息率：
- -
每股收益(TTM):
-4.9510
每股收益(LYR):
-14.8490
淨資產收益率：
-1236.83%
總資產收益率：
-427.27%
市淨率：
0.20
市盈率(LYR):
-0.01
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Propanc Biopharma, Inc.
交易所：
NASDAQ
成立時間：
2007
員工人數：
2
公司地址：
302, 6 Butler Street,Camberwell,Victoria,Australia
官網：
http://www.propanc.com
郵編：
3124
電話：
61 3 9882 0780
傳真：
61 3 9882 9969
簡介：
Propanc Biopharma, Inc.最初於2007年10月15日在澳大利亞維多利亞州墨爾本成立。2010年11月23日，該公司在特拉華州重新註冊並重新註冊。他們是一家發展階段的醫療保健公司，目前專註於為患有胰腺癌、卵巢癌和癌症的患者開發新的癌症治療方法。利用他們的科學和腫瘤學顧問，他們開發了一種合理的抗癌化合物複合配方，這些化合物共同發揮多種作用，旨在控制或防止腫瘤在體內複發和擴散。他們的主要候選產品PRP是他們新配方的變體，涉及酶原，即酶的無活性前體。
董事
名稱
職位
James Nathanielsz
Chief Executive Officer and Director
Annie VanBroekhoven
Independent Director
Josef Zelinger
Independent Director
Joseph Himy
Independent Director
Julian Kenyon
Director
股東
名稱
職位
James Nathanielsz
Chief Executive Officer and Director
Jeannine Zimmerman
Chief Financial Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/PPCB/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PPCB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","market":"US","secType":"STK","nameCN":"Propanc Biopharma, Inc.","latestPrice":0.195,"timestamp":1770670800000,"preClose":0.1898,"halted":0,"volume":616527,"hourTrading":{"tag":"盘前","latestPrice":0.1951,"preClose":0.195,"latestTime":"08:07 EST","volume":24384,"amount":4672.04584512,"timestamp":1770728836838,"change":0.0001,"changeRate":0.000513,"amplitude":0.046667},"delay":0,"changeRate":0.027397260273972657,"floatShares":6733900,"shares":15091099,"eps":-4.951,"marketStatus":"盤前交易","change":0.0052,"latestTime":"02-10 08:14:43 EST","open":0.1841,"high":0.195,"low":0.1785,"amount":114763.78216593,"amplitude":0.086934,"askPrice":0.214,"askSize":1451,"bidPrice":0.182,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.951,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770733800000},"marketStatusCode":1,"adr":0,"listingDate":1743998400000,"exchange":"NASDAQ","adjPreClose":0.195,"preHourTrading":{"tag":"盘前","latestPrice":0.1951,"preClose":0.195,"latestTime":"08:07 EST","volume":24384,"amount":4672.04584512,"timestamp":1770728836838,"change":0.0001,"changeRate":0.000513,"amplitude":0.046667},"postHourTrading":{"tag":"盘后","latestPrice":0.1906,"preClose":0.195,"latestTime":"19:36 EST","volume":32146,"amount":6132.5902,"timestamp":1770683814943,"change":-0.0044,"changeRate":-0.022564,"amplitude":0.055897},"volumeRatio":0.0680923800462348},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPCB\",,,,,undefined,":{"symbol":"PPCB","floatShares":6733900,"roa":"-427.27%","roe":"-1236.83%","lyrEps":-14.848963,"volumeRatio":0.0680923800462348,"shares":15091099,"dividePrice":0,"high":0.195,"amplitude":0.086934,"preClose":0.1898,"low":0.1785,"week52Low":0.0002,"pbRate":"0.20","week52High":11,"institutionHeld":0,"latestPrice":0.195,"committee":-0.871051,"eps":-4.951,"divideRate":0,"volume":616527,"delay":0,"ttmEps":-4.951,"open":0.1841,"prevYearClose":0.536601,"prevWeekClose":0.1898,"prevMonthClose":0.2278,"prevQuarterClose":0.5366,"fiveDayClose":0.2289,"twentyDayClose":0.4622,"sixtyDayClose":0.8406},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPCB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-01-29","symbol":"PPCB","defaultRemindTime":1738161000000,"type":"split","dateTimestamp":1738126800000,"forFactor":60000,"toFactor":1,"ratio":60000},{"market":"US","date":"2023-05-23","symbol":"PPCB","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2020-11-19","symbol":"PPCB","defaultRemindTime":1605796200000,"type":"split","dateTimestamp":1605762000000,"forFactor":1000,"toFactor":1,"ratio":1000},{"market":"US","date":"2019-06-24","symbol":"PPCB","type":"split","dateTimestamp":1561348800000,"forFactor":500,"toFactor":1,"ratio":500}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPCB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPCB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PPCB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PPCB","date":"2026-02-09","current":-0.039386,"percent":1,"low":-1.336323,"twenty":-0.44103,"median":-0.188344,"eighty":-0.105672,"high":-0.040004,"avg":-0.291147,"sd":0.229863,"marketCap":2536533},"quantilePoints":[{"date":"2025-04-04","current":-0.050633,"twenty":-0.050633,"median":-0.050633,"eighty":-0.050633,"marketCap":84546},{"date":"2025-04-07","current":-0.048332,"twenty":-0.050633,"median":-0.050633,"eighty":-0.049713,"marketCap":80703},{"date":"2025-08-22","current":-0.938461,"twenty":-0.969897,"median":-0.655598,"eighty":-0.050633,"marketCap":51812834},{"date":"2025-08-29","current":-0.721182,"twenty":-0.884372,"median":-0.710781,"eighty":-0.050633,"marketCap":39816759},{"date":"2025-09-05","current":-0.457673,"twenty":-0.820575,"median":-0.688821,"eighty":-0.213449,"marketCap":25268328},{"date":"2025-09-12","current":-0.457673,"twenty":-0.778969,"median":-0.631034,"eighty":-0.41283,"marketCap":25268328},{"date":"2025-09-19","current":-0.506214,"twenty":-0.755854,"median":-0.517772,"eighty":-0.439644,"marketCap":27948302},{"date":"2025-09-26","current":-0.418378,"twenty":-0.712861,"median":-0.510837,"eighty":-0.435021,"marketCap":23098825},{"date":"2025-10-03","current":-0.399917,"twenty":-0.699454,"median":-0.498124,"eighty":-0.407301,"marketCap":23564414},{"date":"2025-10-10","current":-0.408611,"twenty":-0.69067,"median":-0.457673,"eighty":-0.403395,"marketCap":24076684},{"date":"2025-10-17","current":-0.343407,"twenty":-0.669984,"median":-0.449583,"eighty":-0.385572,"marketCap":20234660},{"date":"2025-10-24","current":-0.321672,"twenty":-0.645772,"median":-0.432247,"eighty":-0.369488,"marketCap":18953985},{"date":"2025-10-31","current":-0.269509,"twenty":-0.610693,"median":-0.4245,"eighty":-0.343407,"marketCap":15880366},{"date":"2025-11-07","current":-0.241906,"twenty":-0.556142,"median":-0.418378,"eighty":-0.313847,"marketCap":14253909},{"date":"2025-11-14","current":-0.169965,"twenty":-0.518234,"median":-0.404264,"eighty":-0.269509,"marketCap":10014876},{"date":"2025-11-21","current":-0.174454,"twenty":-0.514536,"median":-0.397743,"eighty":-0.234995,"marketCap":11061584},{"date":"2025-11-28","current":-0.188344,"twenty":-0.512687,"median":-0.384703,"eighty":-0.189884,"marketCap":11942288},{"date":"2025-12-05","current":-0.173885,"twenty":-0.509912,"median":-0.372748,"eighty":-0.182127,"marketCap":11025501},{"date":"2025-12-12","current":-0.170028,"twenty":-0.504827,"median":-0.356448,"eighty":-0.174606,"marketCap":10780935},{"date":"2025-12-19","current":-0.151754,"twenty":-0.498818,"median":-0.343407,"eighty":-0.171335,"marketCap":9622255},{"date":"2025-12-26","current":-0.139108,"twenty":-0.496968,"median":-0.326019,"eighty":-0.170682,"marketCap":8820401},{"date":"2026-01-02","current":-0.113099,"twenty":-0.476627,"median":-0.315152,"eighty":-0.168873,"marketCap":7171266},{"date":"2026-01-09","current":-0.101254,"twenty":-0.460447,"median":-0.284723,"eighty":-0.163023,"marketCap":6420182},{"date":"2026-01-16","current":-0.074044,"twenty":-0.457673,"median":-0.262988,"eighty":-0.151375,"marketCap":4694858},{"date":"2026-01-23","current":-0.056065,"twenty":-0.453513,"median":-0.243754,"eighty":-0.138341,"marketCap":3554888},{"date":"2026-01-30","current":-0.058573,"twenty":-0.449352,"median":-0.223866,"eighty":-0.121547,"marketCap":3713923},{"date":"2026-02-06","current":-0.042554,"twenty":-0.442879,"median":-0.192195,"eighty":-0.107345,"marketCap":2698240},{"date":"2026-02-09","current":-0.040004,"twenty":-0.44103,"median":-0.188344,"eighty":-0.105672,"marketCap":2536533}],"updateTime":1770727726239},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":134729532,"yearFounded":2007,"employeeNum":2,"address":"302, 6 Butler Street,Camberwell,Victoria,Australia","zipCode":"3124","officePhone":"61 3 9882 0780","officeFax":"61 3 9882 9969"},"stockCompanyDetail":{"websiteUrl":"http://www.propanc.com","stockEarnings":[{"period":"1week","weight":-0.1481},{"period":"1month","weight":-0.5781},{"period":"3month","weight":-0.768},{"period":"6month","weight":-0.9756},{"period":"1year","weight":974},{"period":"ytd","weight":-0.6366}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Propanc Biopharma, Inc.最初於2007年10月15日在澳大利亞維多利亞州墨爾本成立。2010年11月23日，該公司在特拉華州重新註冊並重新註冊。他們是一家發展階段的醫療保健公司，目前專註於為患有胰腺癌、卵巢癌和癌症的患者開發新的癌症治療方法。利用他們的科學和腫瘤學顧問，他們開發了一種合理的抗癌化合物複合配方，這些化合物共同發揮多種作用，旨在控制或防止腫瘤在體內複發和擴散。他們的主要候選產品PRP是他們新配方的變體，涉及酶原，即酶的無活性前體。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.358631},{"month":2,"riseRate":0,"avgChangeRate":-0.338273},{"month":3,"riseRate":0,"avgChangeRate":-0.122004},{"month":4,"riseRate":0,"avgChangeRate":-0.570113},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.073453},{"month":6,"riseRate":0.666667,"avgChangeRate":0.742287},{"month":7,"riseRate":0.25,"avgChangeRate":-0.019906},{"month":8,"riseRate":0,"avgChangeRate":-0.482224},{"month":9,"riseRate":0,"avgChangeRate":-0.414214},{"month":10,"riseRate":0,"avgChangeRate":-0.267792},{"month":11,"riseRate":0,"avgChangeRate":-0.325477},{"month":12,"riseRate":0.25,"avgChangeRate":-0.177783}],"exchange":"NASDAQ","name":"Propanc Biopharma, Inc.","nameEN":"Propanc Biopharma, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PPCB\",market:\"US\",,,undefined,":{"directors":[{"name":"James Nathanielsz","position":"Chief Executive Officer and Director"},{"name":"Annie VanBroekhoven","position":"Independent Director"},{"name":"Josef Zelinger","position":"Independent Director"},{"name":"Joseph Himy","position":"Independent Director"},{"name":"Julian Kenyon","position":"Director"}],"executives":[{"name":"James Nathanielsz","position":"Chief Executive Officer and Director"},{"name":"Jeannine Zimmerman","position":"Chief Financial Officer"}]}}}